Contact dermatitis due to bufexamac.
D002019:Bufexamac / Q000009:adverse effects* / Q000627:therapeutic use; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects*; D008875:Middle Aged
D006877:Hydroxamic Acids; D002019:Bufexamac